Plain-English translation of NCT06113861 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing a new blood test that might help doctors diagnose tuberculosis in children faster and more reliably. This study will collect blood samples from children who may have tuberculosis to understand how this new test works and whether it can predict how sick a child is and how well they will respond to treatment.
Current tuberculosis tests in children can be slow, difficult to interpret, or unreliable. This new blood-based test could make diagnosis faster and help doctors catch the disease earlier, which is especially important in children who often have harder-to-diagnose forms of the disease.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital or clinic for an initial blood draw before starting any tuberculosis treatment. The research team will collect blood samples and track how you respond to tuberculosis treatment over time. The study is divided into two phases: the first phase (18 months) establishes how the blood test works, and the second phase (18 months) confirms whether the test is reliable in predicting treatment outcomes.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Bolivia
Collaborators
Asociacion Benefica Prisma, Universidad Peruana Cayetano Heredia
Enrollment target
~1,220 participants
Started
April 2024
Primary completion
October 2027
Age range
2 Months – 14 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Richard Oberhelman, MD
Tulane University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.